Polyvalent Nanobody Structure Designed for Boosting SARS-CoV-2 Inhibition.
Ontology highlight
ABSTRACT: Coronavirus transmission and mutations have brought intensive challenges on pandemic control and disease treatment. Developing robust and versatile antiviral drugs for viral neutralization is highly desired. Here, we created a new polyvalent nanobody (Nb) structure that shows the effective inhibition of SARS-CoV-2 infections. Our polyvalent Nb structure, called "PNS", is achieved by first conjugating single-stranded DNA (ssDNA) and the receptor-binding domain (RBD)-targeting Nb with retained binding ability to SARS-CoV-2 spike protein and then coalescing the ssDNA-Nb conjugates around a gold nanoparticle (AuNP) via DNA hybridization with a desired Nb density that offers spatial pattern-matching with that of the Nb binding sites on the trimeric spike. The surface plasmon resonance (SPR) ass
SUBMITTER: Song T
PROVIDER: S-EPMC10965196 | biostudies-literature | 2024 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA